David A. McBride

470 total citations
12 papers, 351 citations indexed

About

David A. McBride is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David A. McBride has authored 12 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David A. McBride's work include CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (3 papers). David A. McBride is often cited by papers focused on CAR-T cell therapy research (5 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (3 papers). David A. McBride collaborates with scholars based in United States and Sweden. David A. McBride's co-authors include Nisarg J. Shah, Joseph Wang, Daniel Kupor, Miguel Angel Lopez‐Ramirez, Jonathan K. Pokorski, Nicole F. Steinmetz, Fernando Soto, Amir Nourhani, Chao Wang and Ricardo Rueda and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

David A. McBride

12 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. McBride United States 9 139 93 85 85 56 12 351
Ricardo Rueda United States 5 192 1.4× 155 1.7× 62 0.7× 66 0.8× 78 1.4× 5 394
Arlind B. Mara United States 7 131 0.9× 56 0.6× 72 0.8× 114 1.3× 54 1.0× 12 324
Daniel Kupor United States 9 191 1.4× 162 1.7× 71 0.8× 81 1.0× 78 1.4× 13 434
Xin Yuan China 13 113 0.8× 117 1.3× 65 0.8× 27 0.3× 63 1.1× 25 474
Shrey Shah United States 7 58 0.4× 139 1.5× 75 0.9× 30 0.4× 23 0.4× 22 357
Brian Lu Canada 9 191 1.4× 89 1.0× 132 1.6× 24 0.3× 39 0.7× 17 400
Christopher Wolff Germany 12 69 0.5× 53 0.6× 90 1.1× 19 0.2× 57 1.0× 16 396
Sharon W. T. Chew Singapore 8 374 2.7× 126 1.4× 106 1.2× 63 0.7× 188 3.4× 8 532
Carl M. Schoellhammer United States 12 340 2.4× 221 2.4× 137 1.6× 22 0.3× 60 1.1× 20 680
Leilei Bao China 13 147 1.1× 199 2.1× 209 2.5× 52 0.6× 70 1.3× 35 572

Countries citing papers authored by David A. McBride

Since Specialization
Citations

This map shows the geographic impact of David A. McBride's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. McBride with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. McBride more than expected).

Fields of papers citing papers by David A. McBride

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. McBride. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. McBride. The network helps show where David A. McBride may publish in the future.

Co-authorship network of co-authors of David A. McBride

This figure shows the co-authorship network connecting the top 25 collaborators of David A. McBride. A scholar is included among the top collaborators of David A. McBride based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. McBride. David A. McBride is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
McBride, David A., et al.. (2024). The therapeutic potential of immunoengineering for systemic autoimmunity. Nature Reviews Rheumatology. 20(4). 203–215. 10 indexed citations
2.
McBride, David A., et al.. (2023). Immunomodulatory Microparticles Epigenetically Modulate T Cells and Systemically Ameliorate Autoimmune Arthritis. Advanced Science. 10(11). e2202720–e2202720. 11 indexed citations
3.
McBride, David A., et al.. (2023). Biodegradable scaffolds for enhancing vaccine delivery. Bioengineering & Translational Medicine. 8(6). e10591–e10591. 4 indexed citations
4.
McBride, David A., M. Kerr, Miriam Bollmann, et al.. (2023). Immunomodulatory Nanoparticles for Modulating Arthritis Flares. ACS Nano. 18(3). 1892–1906. 7 indexed citations
5.
McBride, David A., et al.. (2022). Short-chain fatty acid-mediated epigenetic modulation of inflammatory T cells in vitro. Drug Delivery and Translational Research. 13(7). 1912–1924. 24 indexed citations
6.
McBride, David A., Alexander J. Najibi, Bo Ri Seo, et al.. (2022). Immune‐responsive biodegradable scaffolds for enhancing neutrophil regeneration. Bioengineering & Translational Medicine. 8(1). e10309–e10309. 8 indexed citations
7.
Wang, Quanzeng, et al.. (2021). Infrared Thermography for Measuring Elevated Body Temperature: Clinical Accuracy, Calibration, and Evaluation. Sensors. 22(1). 215–215. 29 indexed citations
8.
McBride, David A., et al.. (2020). Characterization of regulatory T cell expansion for manufacturing cellular immunotherapies. Biomaterials Science. 8(15). 4186–4198. 3 indexed citations
9.
McBride, David A., et al.. (2020). Triggers, Timescales, and Treatments for Cytokine-Mediated Tissue Damage. SHILAP Revista de lepidopterología. 5(1). 52–62. 8 indexed citations
10.
McBride, David A., et al.. (2020). Combining therapeutic vaccines with chemo- and immunotherapies in the treatment of cancer. Expert Opinion on Drug Discovery. 16(1). 89–99. 27 indexed citations
11.
Lopez‐Ramirez, Miguel Angel, Fernando Soto, Chao Wang, et al.. (2019). Built‐In Active Microneedle Patch with Enhanced Autonomous Drug Delivery. Advanced Materials. 32(1). e1905740–e1905740. 212 indexed citations
12.
McBride, David A., et al.. (2019). Applications of molecular engineering in T‐cell‐based immunotherapies. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 11(5). 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026